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Background: The aim of the study was to compare the effects of rosmarinic acid 
and dexpanthenol in a rat experimental wound model. 
Materials and methods: Twenty-four Wistar albino rats weighing 200–250 g 
were randomly divided into three groups. After 2-cm full-thickness skin defects 
were created, the wounds were washed with sterile 0.9% NaCl solution. After 
washing, the control group was left untreated, the second group received 5% 
dexpanthenol cream, and the third group received 10% rosmarinic acid cream. 
Before excision, the skin was evaluated macroscopically by measuring the re-
duction in wound size; after excision, histological examination (epithelisation, 
inflammation, fibrosis, granulation) was performed. 
Results: Macroscopic comparison of the wound sizes showed that group 3 showed 
a statistically significant difference in wound size reduction compared to the other 
two groups. Histopathological examination showed that there was no statistically 
significant difference between the groups. We found that the rosmarinic acid 
group had greater wound size reduction than the other two groups. However, 
epithelialisation was detected in fewer cases.
Conclusions: We believe that rosmarinic acid can be used as a topical cream 
for wound healing, as it leads to significant reduction in wound size, resulting in 
fewer scars. (Folia Morphol 2021; 80, 3: 618–624)
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INTRODUCTION
Wound healing is a serious issue that may be as-
sociated with postoperative morbidity. Wound dehis-
cence and delayed wound healing remain important, 
serious problems in surgery. The basic principle of 
wound healing is to maintain adequate tissue perfu-
sion and oxygenation, the anatomical and functional 
integrity of the affected area, and to ensure proper 
nutrition and moisture environment [17]. Various 
pharmacological agents have been studied for ac-
celerating wound healing and preventing necrosis 
or ischaemia, and extensive efforts are still ongoing. 
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Sympatholytics, vasodilators, calcium channel block-
ers, anti-haemorrhagic agents, prostaglandin inhibi-
tors, honey, anticoagulants, glucocorticoids, and free 
oxygen radical-inhibiting agents have been studied, 
and achieving various degrees of success. The most 
important disadvantages of many pharmacological 
agents are their relatively high doses and systemic 
use, which means that they have various potential 
adverse effects and risks. Local application, on the 
other hand, is more advantageous in terms of these 
risks [1, 6].
Dexpanthenol is widely used in wound healing in 
clinical practice. Pantothenate is a stimulant for mi-
gration, proliferation, and gene regulation in human 
dermal fibroblast cultures. Topical dexpanthenol is 
used both in wound care and for treating dermatolog-
ical diseases because it stimulates skin regeneration 
and promotes wound healing [6].
Topical application of antioxidant-containing com-
pounds is beneficial for wound healing and for pro-
tecting tissues from oxidative damage [8]. In chemical 
and cellular systems, rosmarinic acid (RA) and its basic 
metabolites have antioxidant activity [5]. RA also has 
anti-bacterial and nematicide effects and important 
anti-inflammatory properties [5, 7, 10, 21]. As far as 
we know, the effect of RA on topical wound healing 
has not been investigated.
Dexpanthenol is widely used for small wounds 
and abrasions. Although dexpanthenol has been in-
vestigated widely for its effects on skin disorders, 
there has been insufficient evaluation of the effects 
of both RA and dexpanthenol on wound healing. In 
the present study, we evaluated the effects of topi-
cal RA and dexpanthenol on wound healing in a rat 
experimental wound model.
MATERIALS AND METHODS
This experimental study was submitted to the 
Ethics Committee of our University and approved by 
decision 2016/17 on 13 April, 2016. The experiments 
were performed in the University’s Research and Ap-
plication Centre Laboratory.
Animals
Twenty-four Wistar albino rats, each weighing an 
average of 200–250 g, were used. Starting 1 week 
before the study, the animals were prepared for the 
experiment, and were kept in a 12-h day/night en-
vironment in separate cages and given standard rat 
feed. The animals were randomly divided into three 
groups, and fasted 12 hours before the experiment; 
they were allowed to drink only water.
Skin defect model
All animals were anesthetised by intramuscular 
administration of 50 mg/kg ketamine hydrochloride 
(Ketalar®, Pfizer, Istanbul) and 5 mg/kg xylazine hy-
drochloride (Rompon®, Bayer, Şişli, Istanbul) under 
aseptic conditions. The rats were anesthetised in the 
prone position, shaved, and povidone iodine was 
administered for antisepsis. A full-thickness skin de-
fect 2 cm in length was created with a #11 scalpel 
blade (Fig. 1). The wounds of all animals were cleaned 
with 0.9% NaCl solution, and then the animals were 
divided into three groups.
Rosmarinic acid (96% ALDRICH Chemistry Product, 
UK of United Kingdom) and dexpanthenol (Bepan-
thol®, Bayer Turk Kimya San. Ltd. Sti. Istanbul) were 
used in the study. We used 18 g cold cream (cera alba, 
Olei Amygdalanum, Boracis, aqua rosae, oleum rosae) 
and 2 g powdered RA to prepare 10% RA cream.
Group 1: Control group. After receiving 
a full-thickness skin incision of approximately 2 cm 
on the dorsum, the wound was cleaned daily with 
isotonic saline solution, dressings were performed, 
and each rat was kept in a separate cage.
Group 2: Dexpanthenol group. After receiving 
a full-thickness skin incision of approximately 2-cm 
diameter on the dorsum, the wound was cleaned 
with isotonic saline solution, and then dexpanthenol 
(5% cream) was applied daily; each rat was kept in 
a separate cage.
Group 3: Rosmarinic acid group. After receiving 
a full-thickness skin incision of approximately 2-cm 
diameter on the dorsum, the wound was cleaned 
Figure 1. A, B. Incision model created in rats.
A B
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with isotonic saline solution, and then RA cream 
(10% cream) was applied daily; each rat was kept in 
a separate cage.
Wound healing assessment
The wound healing process was evaluated as fol-
lows: macroscopically, the reduction in wound size 
was calculated, and the excised wound tissue was 
evaluated by histological examination.
Macroscopic evaluation
Following the surgical procedure, the course of 
healing in all wounds was calculated using Walker’s 
formula [20] after fixation of the rats’ drawing on 
acetate paper on day 0, 3, 5, 7, 10, 14, and 21. In 
addition, rats whose wound healing was completed 
were recorded during the daily control.
Walker formula
% Wound area =
Wound area on day X
× 100
Wound area measured on day 1
Histological evaluation
On day 21, all animals were sacrificed, and 5 × 
× 3 cm full-thickness skin, including the incision 
line, was removed from the dorsum for histological 
examination. A qualified pathologist evaluated the 
histopathological examinations. The tissues were 
fixed in 10% buffered formaldehyde solution for 
2 days, and routine follow-up was performed. The 
tissues were embedded in paraffin blocks after the 
follow-up phase. Sections (4 µm) obtained from the 
prepared paraffin blocks were stained with haema-
toxylin and eosin stain, examined under a light micro-
scope, and photographed by a microscope-mounted 
camera. Inflammation, granulation tissue formation, 
and vascularisation were evaluated morphological-
ly. Morphological findings, epithelialisation, cellular 
content (neutrophils, macrophages, fibroblasts), col-
lagen regeneration, and vascularisation were scored 
as follows: 0 — no change; 1 — little change; 2 — 
moderate change; 3 — considerable change.
Statistical analysis
Statistical analysis was performed using SPSS for 
Windows 13.0 (SPSS Inc., Chicago, IL, USA). Categorical 
data were evaluated using the χ2 test. Continuous data 
were evaluated using the Kruskal-Wallis test, and the 
Mann-Whitney U test was used for comparison of two 
groups. P < 0.05 was considered statistically significant.
RESULTS
Evaluation of wound healing scores
The wound healing scores calculated ac-
cording to Walker’s formula in the control, dex-
panthenol, and RA groups are given in Figure 2 
and Tables 1 and 2. The macroscopic and histopatho-
logical evaluations of the groups are as below.
Macroscopic evaluation
In postoperative day 3, the greatest reduction in 
wound size was observed in the control group, but on 
day 10 and later, the greatest reduction in the wound 
size was observed in the RA group. The difference 
was statistically significant. However, no significant 
difference was observed in wound sizes between the 
groups on days 5 and 7.
Histopathological evaluation
When the histopathological examination findings 
were compared statistically, no statistically significant 
difference was found between the groups in terms 
of epithelialisation, inflammation, fibrosis, and gran-
ulation (Figs. 3–5, Table 2).
DISCUSSION
Wound dehiscence and delayed wound heal-
ing are still important, serious problems in surgery. 
A proper wound healing process aims to improve the 
structure and function of the injured tissue. The healing 
process starts during an injury and can last for years 
[7, 10, 20]. Various clinicians use many agents topically 
and systemically for wound healing. Agents that are 
suggested to be useful in wound healing are reported 
to have antioxidant, antimicrobial, antibacterial, and 
anti-inflammatory properties [11, 13, 18]. Topical ap-
plication of antioxidant-containing compounds for 
wound healing and for protecting tissues from oxi-
dative damage has been shown to be beneficial [8].
Figure 2. Reduction in wound size according to day.
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Table 1. Distribution of wound healing score measurements.
Group Day — median (range)
3 5 7 10 14 21
Control 85 (80–95) 68 (51–80) 54.5 (47–75) 34 (32–40) 19.5 (11–23) 9 (6–11)
Dexpanthenol 89.5 (85–93) 70 (65–72) 59 (51–64) 40.5 (37–50) 22 (17–28) 9.5 (7–14)
Rosmarinic acid 94 (89–96) 72.5 (66–83) 52. (44–64) 30 (16–36) 11.5 (9–17) 4.5 (3–7)
P-values (Kruskal-Wallis test) 0.005903 0.397919 0.240973 0.000369 0.000743 0.000712
Figure 3. Microscopic view of wound tissues on day (control group). The area between the two red lines in the section belongs to the in-
cision line (haematoxylin-eosin, ×40) (A). The yellow arrow indicates epithelialisation on the surface of the incision line; the blue arrows 
indicate the fibrotic line and vascular structures (haematoxylin-eosin, ×200) (B). The red arrows indicate the pigmented macrophages of 
hemosiderin in brown at the bottom of the incision line (haematoxylin-eosin, ×200) (C).
Table 2. Comparison of histopathological evaluation results between groups
Parameters Control (%) Dexpanthenol (%) Rosmarinic acid (%) P
Epithelisation Present 6 (75%) 5 (62.5%) 3 (37.5%) 0.1797
Absent 2 (25%) 3 (37.5%) 5 (62.5%)
Inflammation 0 1 (12.5%) 0 (0%) 0 (0%) 0.3302
1 3(37.5%) 3 (37.5%) 3 (37.5%)
2 3 (37,5%) 2 (25%) 5 (62.5%)
3 1 (12.5%) 3 (37.5%) 0 (0%)
Fibrosis 0 0 (0%) 0 (0%) 0 (0%) 0.4932
1 1 (12.5%) 0 (0%) 0 (0%)
2 5 (62.5%) 6 (75%) 4 (50%)
3 2 (25%) 2 (25%) 4 (50%)
Granulation tissue Present 6 (75%) 4 (50%) 5 (50%) 0.6056
Absent 2 (25%) 4 (50%) 3 (50%)
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Mushtaq et al. [14] reported that RA has a pro-
tective effect against liver and kidney oxidative stress 
in diabetic rats. RA has an indirect antioxidant effect 
Figure 4. Microscopic view of wound tissues on day (dexpanthenol group). The area between the two red lines in the section belongs to the 
incision line (haematoxylin-eosin, ×40) (A). The yellow arrow indicates epithelialisation on the surface of the incision line; the blue arrows 
indicate the fibrotic line and vascular structures (haematoxylin-eosin, ×200) (B). The red arrows indicate the pigmented macrophages of  
hemosiderin in brown at the bottom of the incision line (haematoxylin-eosin, ×200) (C).
Figure 5. Microscopic view of wound tissues on day (rosmarinic acid group). The area between the two red lines in the section belongs to 
the incision line (haematoxylin-eosin, ×40) (A). The yellow arrow indicates epithelialisation on the surface in the incision line (haematoxylin- 
-eosin, ×200) (B). The red arrows indicate the hemosiderin pigmented macrophages, and the blue arrows indicate the vascular structures  
at the bottom of the incision line (haematoxylin-eosin, ×200) (C).
by affecting the production of cytoprotective genes 
in the liver, affecting the antioxidant system and 
nuclear factor-erythroid 2-related factor-2 (NRF2)-de-
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pendent phase II enzymes [1, 16]. The antibacterial 
and anti-inflammatory effects of RA have also been 
demonstrated previously [5, 10, 21].
In the present study, a significant reduction in 
wound size was detected in the RA group. On day 3, 
there was a statistically significant difference between 
the three groups in the reduction of wound area. This 
difference is probably due to the anti-inflammatory 
effect of RA. In early postoperative phase (day 3), the 
greatest reduction in wound size was observed in the 
control group, but in late postoperative phase (day 10 
and later), the greatest reduction in wound size was 
observed in the RA group. The difference was statis-
tically significant. However, no significant difference 
was observed in wound sizes between the groups on 
days 5 and 7. However, histopathological examination 
did not reveal a significant difference in epithelisa-
tion, inflammation, fibrosis and granulation. Wound 
healing takes place in a multi-stage, multi-factorial 
mechanism. The reduction in wound size in favour of 
RA may be due to the effect of RA on fibroblast cells. 
Although RA reduced wound size more than dexpan-
thenol and the control group, the wound healing 
time was also partially prolonged in this group. This 
may be due to the blocking of the direct and indirect 
effects of mediators released from inflammatory cells 
due to the anti-inflammatory effect of RA. This may 
explain the inconsistency between the macroscopic 
findings and histomorphological findings.
Aramwit and Sangcakul [2] applied sericin cream 
and achieved 90% improvement on day 11 and 
achieved full recovery on day 15. Kwon et al. [9] 
observed 90% improvement on day 10 and com-
plete closure on day 14 with 14-day administration 
of topical recombinant human epidermal growth 
factor. In the present study, based on the significant 
statistical findings (approximately 90% on day 14; 
> 95% improvement on day 21), we concluded that 
the clinical effect of RA would be seen after day 7 
and that RA should be applied for at least 3 weeks for 
maximum effect. Although the recovery times in our 
study appear slightly longer than that in the above 
studies, we believe that this may have been affected 
by the rat type, wound type, or other environmental 
factors used, as the recovery time in our control group 
was longer than that of their control groups.
Dexpanthenol is widely used in wound healing 
in clinical practice. Pantothenate is a stimulant for 
migration, proliferation, and gene regulation in hu-
man dermal fibroblast cultures. Topical dexpanthenol 
is used both in wound care and in the treatment of 
dermatological diseases because it stimulates skin 
regeneration and promotes wound healing [6]. In 
a wound healing model, Ulger et al. [19] showed 
significantly better healing in the dexpanthenol and 
nebivolol groups than in the control group. Similar-
ly, Oguz et al. [15] observed better recovery in the 
N-acetylcysteine and dexpanthenol groups than in 
the control group. In our study, wound healing in the 
dexpanthenol group was similar to that of the control 
group, although RA group showed significantly better 
recovery than the dexpanthenol group. In addition, 
dexpanthenol caused more epithelialization than RA.
In the RA group, especially on day 7 and later, 
there was greater reduction in wound size compared 
to the other two groups. Histomorphological evalu-
ation did not reveal a significant difference, but the 
evaluation of fibrosis showed that the number of 
RA rats with grade 3 fibrosis was higher than that of 
the other two groups. This finding partially supports 
the above results. Wound contraction is most active 
in the wound healing process between 7 and 10 
days, when fibroblastic cell activation is also high. 
We believe that RA caused an increase in fibroblastic 
activity. More comprehensive studies are needed to 
demonstrate this precisely.
Our histopathological results do not statistically 
support our macroscopic observations. We did not 
find any significant difference in terms of inflamma-
tion between the groups. However, RA has known 
anti-inflammatory effects [4]. On the other hand, 
this effect is usually expressed through the levels of 
anti-inflammatory molecules. However, we did not 
analyse the level of pro-inflammatory molecules. Luo 
et al. [12] reported that RA had an anti-inflamma-
tory effect on acute lung injury by decreasing the 
levels of pro-inflammatory molecules. Chen et al. [3] 
showed that RA ameliorated the fibrosis of pterygium 
epithelial cells by decreasing type I collagen produc-
tion and downregulating transforming growth factor 
β1/Smad signalling. However, we did not find a sta-
tistically significant effect of RA on fibrosis and fi-
broblast activity. This may indicate a need for new 
studies on the histopathological and anti-inflamma-
tory effects of RA in a wound healing model. Unlike 
dexpanthenol, RA also has antibacterial and antiviral 
effects. These effects may lead RA being more effec-
tive than dexpanthenol in wound healing.
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CONCLUSIONS
In conclusion, there was greater reduction of 
wound size in the RA group compared to the dex-
panthenol and control groups, but wound healing 
time was prolonged. In addition, epithelialisation 
was detected in fewer RA cases than in the other two 
groups. Significant reduction in wound size will result 
in less scarring during wound healing. Therefore, we 
believe that RA can be used in a topical cream for 
wound healing. However, additional experimental 
and clinical studies are needed for the duration and 
amount of use.
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